Safety and Tolerability Cerebrolysin: Well-Established Safety Profile Cerebrolysin benefits from decades of post-marketing surveillance and clinical trial safety data: Clinical Trial Safety: Across multiple RCTs, Cerebrolysin has demonstrated a tolerability profile comparable to placebo in most studies, with adverse events generally mild and transient Common Side Effects: Injection site reactions, dizziness, headache, and nausea are the most frequently reported adverse events at standard clinical doses Serious Adverse Events: Rare at therapeutic doses
If you are feeling brain fog, drained or even depleted of the essential minerals and nutrients needed for optimal health, then IV therapy is what you need
No Downtime Resume daily activities immediately after treatment
Common Mistakes to Avoid (And We've Seen Them All) In our experience, when patients have issues with patches, it's almost always due to a handful of common, avoidable mistakes
We have a medical provider on staff who can evaluate, prescribe, and monitor your protocol